Defining Medical Student Patient Care Responsibilities Before Intern Year: Results of a National Survey

King, Christopher; Bolton, Andrew; Guerrasio, Jeannette; Trosterman, Adam

doi:10.14423/smj.0000000000000738

Cited by 4 publications

(2 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…With available data suggesting decreased side effects, once daily dosing, reduction in lab monitoring, and fewer drug–drug interactions with macitentan as opposed to bosentan, one study describing the patient tolerability of a direct switch from one agent to the other was published 52. This was a retrospective assessment of 24 patients who switched from bosentan to macitentan over a two-year period.…”

Section: Safety and Tolerabilitymentioning

confidence: 99%

<p>Safety and tolerability of macitentan in the management of pulmonary arterial hypertension: an update</p>

Wong¹,

Channick²

2019

DHPS

View full text Add to dashboard Cite

Macitentan is a medication in the endothelin receptor antagonist class, approved for treatment of pulmonary arterial hypertension in 2013 based on the results of the pivotal SERAPHIN Trial (Study with an Endothelin Receptor Antagonist in Pulmonary arterial Hypertension to Improve cliNical outcome). Macitentan was shown in initial trials to reduce the likelihood of a morbidity/mortality event. Real-world use of this medication additionally reveals a reduced risk of hospitalizations related to pulmonary arterial hypertension, improved health-related quality of life scores, potential clinical utility in other conditions (such as chronic thromboembolic pulmonary hypertension and pulmonary hypertension related to congenital heart disease), and has a similar safety profile as demonstrated in initial trials.

show abstract

Section: Safety and Tolerabilitymentioning

confidence: 99%

<p>Safety and tolerability of macitentan in the management of pulmonary arterial hypertension: an update</p>

Wong¹,

Channick²

2019

DHPS

View full text Add to dashboard Cite

show abstract

“…Online surveys are an effective method of reaching students from diverse medical schools. 35 In addition, digital collection of data offers a secure and seamless stream, facilitating data analysis. However, their limitation is in understanding how representative the findings are.…”

Section: Limitationsmentioning

confidence: 99%

Current provision of myelopathy education in medical schools in the UK: protocol for a national medical student survey

et al. 2020

View full text Add to dashboard Cite

IntroductionDegenerative cervical myelopathy (DCM) is a common, disabling and progressive neurological condition triggered by chronic compression of the cervical spinal cord by surrounding degenerative changes. Early diagnosis and specialist management are essential to reduce disability, yet time to diagnosis is typically prolonged. Lack of sufficient representation of DCM in undergraduate and postgraduate medical curricula may contribute to the poor recognition of DCM by non-specialist doctors in clinical practice.In this study, our objective, therefore, is to assess DCM teaching provision in medical schools throughout the UK and to assess the impact of teaching on the DCM knowledge of UK medical students.Methods and analysisA 19-item questionnaire capturing data on medical student demographics, myelopathy teaching and myelopathy knowledge was designed. Ethical approval was granted by the Psychology Research Ethics Committee, University of Cambridge. An online survey was hosted on Myelopathy.org, an international myelopathy charity. Students studying at a UK medical school are eligible for inclusion. The survey is advertised nationally through university social media pages, university email bulletins and the national student network of Myelopathy.org. Advertisements are scheduled monthly over a 12-month recruitment period. Participation is incentivised by entering consenting participants of completed surveys to an Amazon voucher prize draw. Responses are anonymised using participant-chosen unique identifier codes. A participant information sheet followed by an explicit survey question captures participant informed consent. Regular updates on the progress of the study will be published on Myelopathy.org.Ethics and DisseminationEthical approval for the study was granted by the Psychology Research Ethics Committee, University of Cambridge (PRE.2018.099). The findings of the study described in this protocol, and all other related work, will be submitted for publication in a peer-reviewed journal and will be presented at scientific conferences.

show abstract

Development and Evaluation of a Direct Care Hospitalist Service Internal Medicine Sub-internship Rotation

Molitch-Hou,

Anderson,

Tewari

et al. 2024

J GEN INTERN MED

View full text Add to dashboard Cite

Defining Medical Student Patient Care Responsibilities Before Intern Year: Results of a National Survey

Cited by 4 publications

References 7 publications

<p>Safety and tolerability of macitentan in the management of pulmonary arterial hypertension: an update</p>

<p>Safety and tolerability of macitentan in the management of pulmonary arterial hypertension: an update</p>

Current provision of myelopathy education in medical schools in the UK: protocol for a national medical student survey

Development and Evaluation of a Direct Care Hospitalist Service Internal Medicine Sub-internship Rotation

Contact Info

Product

Resources

About